Head-to-head · WeighScore
Mixx Health & Wellness vs NuviaRx
The verdict
NuviaRx takes it — 73.5/100 to 62.8/100.
NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mixx Health & Wellness | NuviaRx |
|---|---|---|
| WeighScore | 62.8/100 | 73.5/100 |
| Grade | C | C |
| Scorecard rank | #266 | #69 |
| Semaglutide | Not disclosed | $140/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $170/mo (all doses, compounded) |
| Coverage | 44 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #266 · C
Strengths
- 44 jurisdictions enumerated in the public FAQ — confirm eligibility before intake
- Operating LLC disclosed: Mixx Health and Wellness LLC (Wyoming law)
- Named pharmacy partner: Promise Pharmacy, Palm Harbor FL, (727) 772-0500
- Named founder: Dr. James David Lawrence III, MD, with a public origin story
- $0 consultation fee — free intake and follow-ups
Where it loses points
- Both medications are compounded semaglutide and tirzepatide — not FDA-approved brand drugs
- Dose-tier pricing not available — /pricing and /products pages returned 404
- No LegitScript, PCAB, or BBB trust badges visible
- Wyoming governing-law clause — disputes adjudicated under Wyoming law regardless of your state
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #69 · C
Strengths
- Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
- Free delivery included; clinical evaluation and prescription bundled (if eligible)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
- Named operating entity (NuviaRx Health Inc.) with a US address and phone support
Where it loses points
- Compounding pharmacy partner not named ('partner pharmacy')
- Not LegitScript-certified (no certification displayed)
- Lowest pricing is 'as low as' — likely requires a longer prepaid plan
- State availability not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.